Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2022 | Identifying post-transplant secondary pulmonary infections

Michael Boeckh • 28 Oct 2022
COSTEM 2022
General

Michael Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center, Washington, WA, discusses various secondary respiratory tract infections patients may receive after stem cell transplantation, especially in immunocompromised individuals. Infections such as respiratory syncytial virus (RSV), human metapneumovirus and parainfluenza viruses may negatively affect outcomes and Dr Boeckh highlights research in the epidemiology and management of these diseases, as well as how the immune system controls infection. This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Michael Boeckh

1:17
Letermovir prophylaxis to prevent infection after HSCT
Michael Boeckh • 28 Oct 2022

Related Videos

2:00
The effectiveness of ambulatory care for patients undergoing stem cell transplantation
Amy Colada • 29 Apr 2024
2:04
The safety & efficacy of loperamide prior to stool sample results in patients undergoing SCT
Mohammad Sohomow • 29 Apr 2024
3:11
Exercise as an underutilized tool in cancer care
Rebecca Robinson • 23 Apr 2024
2:30
The impact of conflict on access to cancer therapies
Richard Sullivan • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals